Section 1c: FHIR®
Section 3: Implementation Guides
HL7 FHIR® Implementation Guide: NHSN Adverse Drug Event - Hypoglycemia Report, Release 1- US Realm
This IG supports electronic submission of adverse drug event (ADE) data to the National Healthcare Safety Network (NHSN). The project establishs an electronic submission standard that is vendor-neutral that leverages existing workflows and eliminates duplicate documentation.
HL7 FHIR® Implementation Guide: NHSN Adverse Drug Event - Hypoglycemia Report, Release 1- US Realm may also go by the following names or acronyms:
- Enables improved patient safety and facilitate quality improvement effort
- Enable EHRs of acute care facilities to serve as source systems for reporting ADE data to the National Healthcare Safety Network (NHSN) via industry electronic messages.
- Nebraska Medicine
This IG addresses blood glucose and medication administration events in inpatient settings only and does not include hypoglycemia resulting only in outpatient care (e.g., hypoglycemia resulting in emergency medical services, physician office visits, or emergency department visits only). This IG addresses ADE data collection at the patient-level (i.e., collects individual laboratory and point-of-care-blood glucose and individual medication data for each inpatient encounter). The IG does not describe the calculation of any measures for hypoglycemia rates; these measures are intended to be calculated, aggregated, or risk-adjusted subsequent to reporting of patient-level data to CDC.
|HL7 FHIR® Implementation Guide: NHSN Adverse Drug Event - Hypoglycemia Report, Release 1- US Realm|
|HL7 FHIR® Implementation Guide: NHSN Adverse Drug Event - Hypoglycemia Report, Release 1- US Realm See the standard at http://hl7.org/fhir/us/nhsn-ade/STU1.||(Submit Feedback on STU)|
- Public Health
RESPONSIBLE WORK GROUP
- Implementation Guide
- Clinical and Public Health Laboratories
- EHR, PHR Vendors
- Healthcare Institutions
- Quality Reporting Agencies
- US Realm